Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination TherapyPrasun Mishra(National Institutes of Health), Glenn Merlino(National Cancer Institute)PLoS ONENovember 15, 201610.1371/journal.pone.0165102Cited by 19SaveCiteExport RISWatch citationsRelated Papers“Glowing Head” Mice: A Genetic Tool Enabling Reliable Preclinical Image-Based Evaluation of Cancers in Immunocompetent Allografts|PLoS ONE|2014|52